{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T07:46:30Z","timestamp":1758267990229,"version":"3.41.2"},"reference-count":39,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T00:00:00Z","timestamp":1709856000000},"content-version":"vor","delay-in-days":36,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Cancer Medicine"],"published-print":{"date-parts":[[2024,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Purpose<\/jats:title><jats:p>Intensity\u2010modulated radiotherapy (IMRT) combined with concurrent chemotherapy is deemed as the mainstay treatment in locoregionally advanced nasopharyngeal carcinoma (NPC). Nevertheless, the tolerance of severe acute toxicity of concurrent chemotherapy was unsatisfied. In addition, T4 is the predicting factor of poor prognosis for NPC patients. In this retrospective analysis, the long\u2010term outcomes IMRT combined by induction chemotherapy deleting concurrent chemotherapy with or without adjuvant chemotherapy for T4 non\u2010metastatic NPC were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>From January 2005 to November 2016, a total of 145 biopsy\u2010proven non\u2010metastatic T4 NPC was treated with IMRT combined by induction chemotherapy with or without adjuvant chemotherapy. The survival and side effects of the patients were analyzed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Median follow\u2010up time was 74\u2009months (ranges, 8\u2013186\u2009months). 10.0%, 61.3%, 27.3%, and 1.3% developed grade 1, 2, 3, and 4 mucositis during IMRT, respectively. 5.5% and 2.0% patients experienced grade 1 and 2 nausea and vomiting; no patients developed grade 3 or 4 nausea and vomiting. Of 145 patients enrolled, 5\u2010year and 10\u2010year overall survival(OS) rates were 73.7% and 53.9%, local progression\u2010free survival(LPFS) rates were 86.1% and 71.6%, regional progression\u2010free survival(RPFS) rates were 96.7% and 92.8%, distant metastasis\u2010free survival (DMFS) rates were 86.7%, 78.2%, respectively. At the last follow\u2010up, five patients developed cranial nerve injury, one patient developed mandibular bone necrosis, four patients developed temporal lobe injury, four patients developed nasopharyngeal massive hemorrhage (three cases after recurrence and one case without recurrence), and five patients developed second primary tumor.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The survival outcomes of treating T4 NPC IMRT combined by induction chemotherapy deleting concurrent chemotherapy with or without adjuvant chemotherapy are encouraging. Moreover, mucosal reaction, nausea, and vomiting reaction were reduced during IMRT.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cam4.6578","type":"journal-article","created":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T15:54:32Z","timestamp":1709913272000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Deletion of concurrent chemotherapy on the basis of sequential chemoradiotherapy for non\u2010metastatic stage <scp>T4<\/scp> nasopharyngeal carcinoma in <scp>IMRT<\/scp> era"],"prefix":"10.1002","volume":"13","author":[{"given":"Yuming","family":"Zheng","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology Fudan University Shanghai Cancer Center  Shanghai China"},{"name":"Department of Oncology Shanghai Medical College  Shanghai China"},{"name":"Shanghai Clinical Research Center for Radiation Oncology  Shanghai China"},{"name":"Shanghai Key Laboratory of Radiation Oncology  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fen","family":"Xue","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fudan University Shanghai Cancer Center  Shanghai China"},{"name":"Department of Oncology Shanghai Medical College  Shanghai China"},{"name":"Shanghai Clinical Research Center for Radiation Oncology  Shanghai China"},{"name":"Shanghai Key Laboratory of Radiation Oncology  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9485-6042","authenticated-orcid":false,"given":"Dan","family":"Ou","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fudan University Shanghai Cancer Center  Shanghai China"},{"name":"Department of Oncology Shanghai Medical College  Shanghai China"},{"name":"Shanghai Clinical Research Center for Radiation Oncology  Shanghai China"},{"name":"Shanghai Key Laboratory of Radiation Oncology  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoshuang","family":"Niu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fudan University Shanghai Cancer Center  Shanghai China"},{"name":"Department of Oncology Shanghai Medical College  Shanghai China"},{"name":"Shanghai Clinical Research Center for Radiation Oncology  Shanghai China"},{"name":"Shanghai Key Laboratory of Radiation Oncology  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaosu","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fudan University Shanghai Cancer Center  Shanghai China"},{"name":"Department of Oncology Shanghai Medical College  Shanghai China"},{"name":"Shanghai Clinical Research Center for Radiation Oncology  Shanghai China"},{"name":"Shanghai Key Laboratory of Radiation Oncology  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1652-3012","authenticated-orcid":false,"given":"Xiayun","family":"He","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Fudan University Shanghai Cancer Center  Shanghai China"},{"name":"Department of Oncology Shanghai Medical College  Shanghai China"},{"name":"Shanghai Clinical Research Center for Radiation Oncology  Shanghai China"},{"name":"Shanghai Key Laboratory of Radiation Oncology  Shanghai China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,3,8]]},"reference":[{"key":"e_1_2_10_2_1","unstructured":"GLOBAL.Cancer Observatory.2020; Available from:https:\/\/gco.iarc.fr\/"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.5420"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.12.004"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2017.03.015"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-021-2405-3"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-021-08036-8"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2021.08.022"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30850"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-019-02925-z"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-015-0076-9"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.2179"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-604"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.22.00327"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104666"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7849"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2021.101324"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2022.03.273"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(20)30527-1"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(20)30932-6"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.20.03128"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.12.035"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(22)00058-4"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2022.106139"},{"issue":"16","key":"e_1_2_10_25_1","first-page":"1","article-title":"Reduced\u2010dose radiotherapy for pretreatment EBV DNA selected low\u2010risk stage III nasopharyngeal carcinoma: a single\u2010arm, phase II trial","volume":"40","author":"Mai HQ","year":"2022","journal-title":"J Clin Oncol"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101625"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1200\/jco.21.01467"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.13997"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000018484"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104925"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.11.024"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2012.08.013"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40880-017-0245-0"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2014.01.017"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.13564"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/hed.27315"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2020.104820"},{"key":"e_1_2_10_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-16422-w"},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.10.026"},{"key":"e_1_2_10_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/md.0000000000027023"}],"container-title":["Cancer Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cam4.6578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T05:03:30Z","timestamp":1710219810000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/cam4.6578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":39,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1002\/cam4.6578"],"URL":"https:\/\/doi.org\/10.1002\/cam4.6578","archive":["Portico"],"relation":{},"ISSN":["2045-7634","2045-7634"],"issn-type":[{"type":"print","value":"2045-7634"},{"type":"electronic","value":"2045-7634"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"2023-04-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-12","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-08","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e6578"}}